Comparing two pacing methods after heart valve surgery
Official title: Ranodmized Study of Physiological vs Right Ventricular Pacing in Patients With Normal Ventricular Function Post TAVI (PHYSTAVI II)
Run by Hospital Clinic of Barcelona · NCT06197503 · Data updated 2026-11-12
This study is testing whether a new way of pacing the heart after valve surgery can help patients feel better and have better heart function compared to a standard method.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 48 (estimated) |
| Sponsor | Hospital Clinic of Barcelona Academic / other |
| Locations | 1 site (Barcelona) |
| Status | Recruiting |
| Started | November 30, 2023 |
| Main results expected | December 15, 2025 |
| Study ends | December 15, 2026 |
| Registry record updated | March 31, 2026 |
| Trial ID | NCT06197503 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with AV block who have undergone successful TAVI and have a left ventricular ejection fraction greater than 50%.
✕Probably not a fit
Patients with ventricular dysfunction, those undergoing transapical TAVI, or those with a life expectancy of less than 12 months may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial investigates the effects of physiological pacing versus right ventricular pacing in patients who have undergone transcatheter aortic valve implantation (TAVI) and have preserved left ventricular function. It aims to determine which pacing strategy leads to better clinical outcomes and echocardiographic parameters over a 12-month period. The study will include 24 patients with AV block and will assess various health metrics, including survival rates, quality of life, and heart function. Participants will be randomly assigned to one of the two pacing methods to evaluate their effectiveness.
Why it matters
Potential benefit: If successful, this study could identify the optimal pacing strategy for patients post-TAVI, potentially improving their quality of life and clinical outcomes.
How similar studies have gone: While this approach is exploratory, similar studies have shown promising results in optimizing pacing strategies in cardiac patients.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Successful implantation of TAVI according to VARC-3 criteria. * Indication of cardiac pacing due to AV block according to ESC Guidelines. * LVEF\> 50%. * The patient must indicate their acceptance to participate in the study by signing an informed consent document. Exclusion Criteria: * Ventricular dysfunction: LVEF \<50%. * Transapical TAVI. * Participating currently in a clinical investigation that includes an active treatment. * Patients with left bundle branch block but without indication of pacing (AV block). * Life expectancy \<12 months.
Where it's running
-
Hospital Clínic de Barcelona
Barcelona, Spain Recruiting
Study contacts
- Study coordinator: Lluís Mont, MD, PhD
- Email: lmont@clinic.cat
- Phone: 93 2271778 Ext. 2094
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SPIKE FLOW endocardial pacing lead safety and performance study
This study tests whether the SPIKE FLOW temporary endocardial pacing lead is safe and effective in adults needing temporary pacing during heart-related conditions.
-
Micra AV2 leadless pacemaker to improve AV synchrony in AV block
This study will test whether the Micra AV2 leadless pacemaker improves AV synchrony and is safe for adults with high‑degree AV block who have normal sinus rhythm.
-
Comparing two pacemaker pacing methods for AV block
This trial tests whether conduction system (left bundle branch area) pacing or standard right ventricular pacing works better for people with atrioventricular block who need a permanent pacemaker.
-
Left bundle branch area pacing with Tendril STS or UltiPace leads
This study will try left bundle branch area pacing with the Tendril STS or UltiPace lead in adults who need pacemaker leads for bradycardia or related heart conditions to see if pacing and sensing are safe and work through six months after implant.
-
LivIQ leadless pacemaker system for ventricular pacing
This trial will test the LivIQ leadless pacemaker in adults who need ventricular pacing (VVI or VDD) to see if it is safe and maintains appropriate heart rhythm and AV timing.
-
Comparing two pain management techniques for patients undergoing heart valve replacement
This study is testing two different pain relief methods for patients having heart valve replacement surgery to see which one helps them feel better after the procedure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.